[Pathogenesis and clinical practice of heparin-induced thrombocytopenia and thrombosis].
Matsuo
Takefumi
T
D000925:Anticoagulants / Q000009:adverse effects; D001323:Autoantibodies / Q000032:analysis*; D006348:Cardiac Surgical Procedures; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000601:surgery; D005343:Fibrinolytic Agents / Q000009:adverse effects; D006493:Heparin / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D019637:Orthopedic Procedures; D006435:Renal Dialysis; D012680:Sensitivity and Specificity; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000209:etiology / Q000276:immunology; D013927:Thrombosis / Q000139:chemically induced* / Q000209:etiology / Q000276:immunology
D000925:Anticoagulants; D001323:Autoantibodies; D005343:Fibrinolytic Agents; D006493:Heparin